William Trenton Webb - 05 Mar 2026 Form 4 Insider Report for Surgery Partners, Inc. (SGRY)

Reporting relationship: American Group President
Issuer ticker: SGRY
Reported as of: 05 Mar 2026
Net transaction value: -$28,654
SEC form: 4
Accepted by SEC: 09 Mar 2026, 19:32:59 UTC
Prior SEC filing: 17 Mar 2025
Source filing: View source filing
Reporting owner signature: /s/ Jennifer Baldock, Attorney-in-Fact

Key filing fact

William Trenton Webb filed Form 4 for Surgery Partners, Inc. (SGRY) on 09 Mar 2026.

Key facts

This page summarizes William Trenton Webb's Form 4 filing for Surgery Partners, Inc. (SGRY).
4 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 09 Mar 2026, 19:32.

Change

Previous filing in this sequence was filed on 17 Mar 2025.
Current net transaction value: -$28,654.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002034231 Primary reporting owner

Webb William Trenton

Relationship: American Group President
Address: 340 SEVEN SPRINGS WAY, SUITE 600, BRENTWOOD
Signature: /s/ Jennifer Baldock, Attorney-in-Fact
Signature date: 09 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SGRY transaction

Common Stock

Sale

Transaction value: $3,789
Shares: -272
Change %: -0.36%
Price: $13.93
Shares after: 74,249
Date: 06 Mar 2026
Ownership: Direct
Footnotes: F1, F2

SGRY transaction

Common Stock

Sale

Transaction value: $24,865
Shares: -1,794
Change %: -2.4%
Price: $13.86
Shares after: 72,455
Date: 05 Mar 2026
Ownership: Direct
Footnotes: F2, F3

SGRY transaction

Common Stock

Award

Transaction value
Shares: +20,454
Change %: +28%
Price: $14.11^*
Shares after: 92,909
Date: 05 Mar 2026
Ownership: Direct
Footnotes: F4

SGRY transaction

Common Stock

Award

Transaction value
Shares: +11,438
Change %: +12%
Price: $14.11^*
Shares after: 104,347
Date: 05 Mar 2026
Ownership: Direct
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 2, 2026.

Footnote F2

The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Footnote F3

Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 28, 2026.

Footnote F4

Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the first anniversary of the Grant Date.

Footnote F5

Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the second anniversary of the Grant Date.